Citing the World Health Organization, Bloomberg reported that Europe has surpassed one million deaths from Covid-19 and the situation remains “serious”, with about 1.6 million new cases reported each week in the region. Malaysia also saw the new Covid-19 cases increased further yesterday to breach the 2,000 mark with 2,148 cases. The last time the country registered daily new infections above the 2,000 mark was on March 5 with 2,154 cases.
ASP - Still Strong
However, we do not expect ASP to fall off a cliff despite average lead time being reduced from 300 days in early Jan 2021 to 200 days currently, compared to 20-30 days pre-COVID-19 supported by post-pandemic demand growth averaging 15%-20% per annum. ASP trend is expected to soften next year albeit at a slow pace on the back of still robust demand. Malaysian glove players which commands 68% global market share and have consistently evolve and innovate in terms of capacity, products and plant modernization via automation.
Global demand growth at 15-20% per annum post-COVID-19.
According to the Malaysian Rubber Glove Manufacturers Association, the global shortage of rubber gloves will sustain beyond 1Q 2022 with growth rate averaging between 15% and 20% per annum going forward compared to pre-COVID-19 of 8%-10%.
Heightened Hygiene Awareness
Heightened hygiene awareness extending beyond the healthcare sector. Incremental volume growth is expected from new users of examination rubber gloves including nitrile and latex-based ones.
New cases of 'double mutant' COVID-19 variant detected in U.S. state 12021-04-09 14:29:44CGTNEditor : Zhang MingxinECNS App Download Special: Battle Against Novel Coronavirus Five new cases infected with a "double mutant" of COVID-19 variant have been identified in the San Francisco Bay Area, California, CNBC reported on Thursday. The new cases were identified days after the area reported the first such case.
The variant was first detected in India last month. It was dubbed "double mutant" as it carries two mutations of SARS-CoV-2 strains E484Q and L452R.
These mutations are not new. The E484 was also present in the variant that was first detected in South Africa and Brazil. And the L452R mutation was observed in the U.S. and Europe, but the new variant carries both of them. "Something that has not been seen in other variants," the CNBC reported.
It is suspected to be more contagious and reduce the effectiveness of existing vaccines.
"We don't quite know that yet, although these mutations I've talked about have been associated with increased transmissibility," Dr Benjamin Pinsky, medical director of Stanford's clinical virology laboratory, which discovered the new variant in the U.S., said in the ABC7's show "Getting Answers" on Wednesday. "In fact, in India, this new variant accounts for 15 to 20 percent of cases in one particular state."
It also remains unknown whether the vaccines will be less effective against the variant, but researchers have some information on experiments on the individual mutations suggesting that "antibodies will be less able to neutralize" the variant, Pinsky added.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Iknow666
495 posts
Posted by Iknow666 > 2021-04-16 16:50 | Report Abuse
Glove rally until next week!!